AAAAAA

   
Results: 1-12 |
Results: 12

Authors: REN S KALHORN TF MCDONALD GB ANASETTI C APPELBAUM FR SLATTERY JT
Citation: S. Ren et al., PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND ITS METABOLITES IN BONE-MARROW TRANSPLANTATION PATIENTS, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 289-301

Authors: AMORE BM KALHORN TF SKILES GL HUNTER AP BENNETT GD FINNELL RH NELSON SD SLATTERY JT
Citation: Bm. Amore et al., CHARACTERIZATION OF CARBAMAZEPINE METABOLISM IN A MOUSE MODEL OF CARBAMAZEPINE TERATOGENICITY, Drug metabolism and disposition, 25(8), 1997, pp. 953-962

Authors: SCISM JL POWERS KM ARTRU AA CHAMBERS AC LEWIS L ADKISON KK KALHORN TF SHEN DD
Citation: Jl. Scism et al., EFFECTS OF PROBENECID ON BRAIN-CEREBROSPINAL FLUID-BLOOD DISTRIBUTIONKINETICS OF E-DELTA(2)-VALPROIC ACID IN RABBITS, Drug metabolism and disposition, 25(12), 1997, pp. 1337-1346

Authors: REN S YANG JS KALHORN TF SLATTERY JT
Citation: S. Ren et al., OXIDATION OF CYCLOPHOSPHAMIDE TO 4-HYDROXYCYCLOPHOSPHAMIDE AND DESCHLOROETHYLCYCLOPHOSPHAMIDE IN HUMAN LIVER-MICROSOMES, Cancer research, 57(19), 1997, pp. 4229-4235

Authors: SLATTERY JT KALHORN TF MCDONALD GB LAMBERT K BUCKNER CD BENSINGER WI ANASETTI C APPELBAUM FR
Citation: Jt. Slattery et al., CONDITIONING REGIMEN-DEPENDENT DISPOSITION OF CYCLOPHOSPHAMIDE AND HYDROXYCYCLOPHOSPHAMIDE IN HUMAN MARROW TRANSPLANTATION PATIENTS, Journal of clinical oncology, 14(5), 1996, pp. 1484-1494

Authors: LILLIBRIDGE JH AMORE BM SLATTERY JT KALHORN TF NELSON SD FINNELL RH BENNETT GD
Citation: Jh. Lillibridge et al., PROTEIN-REACTIVE METABOLITES OF CARBAMAZEPINE IN MOUSE-LIVER MICROSOMES, Drug metabolism and disposition, 24(5), 1996, pp. 509-514

Authors: LILLIBRIDGE JA KALHORN TF SLATTERY JT
Citation: Ja. Lillibridge et al., METABOLISM OF LISOFYLLINE AND PENTOXIFYLLINE IN HUMAN LIVER-MICROSOMES AND CYTOSOL, Drug metabolism and disposition, 24(11), 1996, pp. 1174-1179

Authors: BENNETT GD AMORE BM FINNELL RH WLODARCZYK B KALHORN TF SKILES GL NELSON SD SLATTERY JT
Citation: Gd. Bennett et al., TERATOGENICITY OF CARBAMAZEPINE-10,11-EPOXIDE AND OXCARBAZEPINE IN THE SWV MOUSE, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1237-1242

Authors: MITRA AK THUMMEL KE KALHORN TF KHARASCH ED UNADKAT JD SLATTERY JT
Citation: Ak. Mitra et al., INHIBITION OF SULFAMETHOXAZOLE HYDROXYLAMINE FORMATION BY FLUCONAZOLEIN HUMAN LIVER-MICROSOMES AND HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 332-340

Authors: MITRA AK THUMMEL KE KALHORN TF KHARASCH ED UNADKAT JD SLATTERY JT
Citation: Ak. Mitra et al., METABOLISM OF DAPSONE TO ITS HYDROXYLAMINE BY CYP2E1 IN-VITRO AND IN-VIVO, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 556-566

Authors: MYERS TG THUMMEL KE KALHORN TF NELSON SD
Citation: Tg. Myers et al., PREFERRED ORIENTATIONS IN THE BINDING OF 4'-HYDROXYACETANILIDE (ACETAMINOPHEN) TO CYTOCHROME-P450 1A1 AND 2B1 ISOFORMS AS DETERMINED BY C-13-NMR AND N-15-NMR RELAXATION STUDIES, Journal of medicinal chemistry, 37(6), 1994, pp. 860-867

Authors: ZAND R NELSON SD SLATTERY JT THUMMEL KE KALHORN TF ADAMS SP WRIGHT JM
Citation: R. Zand et al., INHIBITION AND INDUCTION OF CYTOCHROME P4502E1-CATALYZED OXIDATION BYISONIAZID IN HUMANS, Clinical pharmacology and therapeutics, 54(2), 1993, pp. 142-149
Risultati: 1-12 |